drugset / Trial / NCT06932393
Exosomes for Hairloss Treatment
RandomizedCrossoverDouble-blindTreatment
Summary
Many people suffer from alopecia, which is caused by hereditary factors, emotional stress, and psychiatric disorders. There are devastating physical and psychological consequences as a result. Exosomes are isolated from donated human mesenchymal stem cells and purified using specific processing. This study is a randomized, double-blind, dose-escalation clinical trial designed to evaluate the efficacy and safety of exosomes therapy for alopecia.
Timeline
- Start
- 2025-04-30
- Primary completion
- 2026-04-17
- Completion
- 2026-04-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exosomes | Other / unclassified | 5e+08 unknown | Other |
| Subject | Exosomes | Other / unclassified | 5e+09 unknown | Other |